A study of the immunology of the chronic fatigue syndrome: Correlation of immunologic parameters to health dysfunction

Clinical Immunology and Immunopathology

Volumn 87, Issue 1, 1998, Pages 60-67

  Hassan, I S ^a   Bannister, B A ^a   Akbar, A ^a   Weir, W ^a   Bofill, M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Anti apoptosis; CFS; Health dysfunction; Immunoactivation

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; PHYTOHEMAGGLUTININ;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031924322     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4512     Document Type: Article

References (46)

1. Kibler R., Lucas D., Hicks M., Poulos B., Jones J. Immune function in chronic active Epstein-Barr virus infection. J. Clin. Invest. 5:1985;46-54.
2. Caliguri M., Murray C., Buchwald D. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 139:1987;3303-3313.
3. Klimas N., Salvato F., Morgan R., Fletcher M. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 28:1990;1403-1410.
4. Gupta S., Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand. J. Immunol. 33:1991;319-327.
5. Straus S., Fritz S., Dale J., Gould B., Strober W. Lymphocyte phenotype and function in the chronic fatigue syndrome. J. Clin. Immunol. 13:1993;30-40.
6. Tirelli U., Marotts G., Improta S., Pinto A. Immunological abnormalities in patients with chronic fatigue syndrome. Scand. J. Immunol. 40:1994;601-608.
7. Landay A., Jessop C., Lennette E., Levy J. Chronic fatigue syndrome: Clinical condition associated with immune activation. Lancet. 338:1991;707-712.
8. Herberman R. B. Sources of confounding in immunological data. Rev. Infect. Dis. 13:1991;S84-S86.
9. Swannick C. M., Vercoulen J. H., Galama J. M., Roos M. T., Meyaard L., van der Ven-Jongerkrijg J. Lymphocyte subsets, apoptosis and cytokines in patients with chronic fatigue syndrome. J. Infect. Dis. 173:1996;460-463.
10. Straus S., Fritz S., Dale J., Gould B., Strober W. Lymphocyte phenotype and function in the chronic fatigue syndrome. J. Clin. Immunol. 13:1993;30-40.
11. Peakman M., Deale A., Field R., Mahalingam, Wessely S. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clin. Immunol. Immunopathol. 82:1997;83-90.
12. Lloyd A., Hickie I., Wakefield D., Boughton C., Dwyer J. A double-blind placebo controlled trial of intravenous immunoglobulin therapy in patients with the chronic fatigue syndrome. Am. J. Med. 89:1990;561-568.
13. Suhadolnik R. J., Reichenbach N. L., Hitzges P., Sobol R. W., Peterson D. L., Henry B. Upregulation of the 2-5A synthetase/RNAse L antiviral pathway associated with chronic fatigue syndrome. Clin. Infect. Dis. 18:1994;S96-S104.
14. See D. M., Tilles J. G. Alpha interferon treatment of patients with chronic fatigue syndrome. Immunol. Invest. 25:1996;153-164.
15. Lucas P. J., Negishi I., Nakayama K., Fields L. E., Loh D. Y. Naive CD28-deficient T cells can initiate but not sustain an in-vitro antigen-specific immune response. J. Immunol. 154:1995;5757-5768.
16. L. Immunity. 3:1995;87-98.
17. Paul W. E., Seder R. O. Lymphocytes responses and cytokines. Cell. 76:1994;241-251.
18. Akbar A. N., Salmon M., Savill J., Janossy G. A possible role for bcl-2 in regulating T-cell memory a 'balancing act' between cell death and survival. Immunol. Today. 11:1993;526-532.
19. Korsmeyer S. J. Bcl 2 initiates a new category of oncogenes: regulators of cell death. Blood. 80:1992;879-886.
20. Nagata S., Goldstein P. Thefasdeath factor. Science. 267:1995;1449-1456.
21. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homologue, bax that accelerates programmed cell death. Cell. 74:1993;606-619.
22. +T cell apoptosis in patients with acute herpesvirus infections: Loss of co-stimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression. Immunology. 88:1996;508-515.
23. Akbar A. N., Borthwick N., Salmon M., Gombert W., Bofill M., Shamsadeen N., Pilling D., Pett S., Grundy J. E., Janossy G. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J. Exp. Med. 178:1993;427-438.
24. -T cells. AIDS. 8:1994;431-441.
25. +patients. Am. J. Pathol. 146:1995;1542-1555.
26. Griffin D. E. Immunologic abnormalities accompanying acute and chronic viral infections. Rev. Infect. Dis. 139:1991;S129-S133.
27. Brazier J. E., Harper R., Jones N. M. B. Validating the SF-36 Health Survey questionnaire: New outcome measure for primary care. Br. Med. J. 305:1992;160-164.
28. Jenkinson C., Coulter A., Wright L. Short form 36 (SF 36) health survey questionnaire: Normative data for adults of working age. Br. Med. J. 306:1993;1437-1440.
29. Garatt A. M., Ruta D. A., Abdalla M. I., Buckingham J. K., Russel I. T. The SF 36 health survey questionnaire: An outcome measure suitable for routine use within the NHS? Br. Med. J. 306:1993;1440-1444.
30. Goldberg D. P., Hillier V. F. A scaled version of the general health questionnaire. Psychol. Med. 9:1979;139-145.
31. Sharpe M., Archard L., Banatvala J. Chronic fatigue syndrome: Guidelines for research. J. R. Soc. Med. 84:1991;118-121.
32. Jenkinson C., Layte R., Wright L., Coulter A. The U.K. SF-36: An Analysis and Interpretation Guide. 1996;Oxford Univ. Press, London.
33. Lloyd A., Hickie I., Hickie C., Dwyer J., Wkefield D. Cell-mediated immunity in patients with the chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin. Exp. Immunol. 87:1992;76-79.
34. Prieto J., Subir M. L., Castilla A., Serrano M. Naloxone-reversible monocyte dysfunction in patients with the chronic fatigue syndrome. Scand. J. Immunol. 30:1989;13-20.
35. Mawle A. C., Nisenbaum R., Dobbins J. G., Gary H. E. Jr., Stewart J. A., Reyes M. Immune responses associated with chronic fatigue syndrome: A case-control study. J. Infect. Dis. 175:1997;136-141.
36. Kronfol Z., Silva J., Or, Greden J., Dembinski S., Gardner R., Carroll B. Impaired lymphocyte function in depressive illness. Life Sci. 33:1983;241-247.
37. Maes M., Jacobs J., Lambreckhts J. Evidence for a systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with antibody staining. Psychol. Med. 22:1992;45-53.
38. Dutra W. O., Martins-Filho O. A., Cancado J. R., Pinto-Dias J. C., Brener Z., Gazzinelli G. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand. J. Immunol. 43:1996;88-93.
39. Akbar A. N., Borthwick N. J., Wickremasinghe R. G., Panayiotidis P., Pilling D., Bofill M. Interleukin-2 receptor common chain signalling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bc1-2, bcl-xL)but notpro-apoptotic (bax bcI-xs) gene expression. Eur. J. Immunol. 26:1996;294-299.
40. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
41. Klimas N., Salvato F., Morgan R., Fletcher M. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 28:1990;1403-1410.
42. Cheney P. R., Dorman S. E., Bell D. S. Interleukin-2 and the chronic fatigue syndrome. Ann. Int. Med. 110:1989;321.
43. Chao C. C., Gallagher M., Phair J., Peterson P. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J. Infect. Dis. 162:1990;1412-1413.
44. MacDonald K. L., Osterholm M. T., LeDell K. H., White K. E., Schenk C. H., Choe C. C. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am. J. Med. 100:1996;548-554.
45. Buchwald D., Cheney P. R., Peterson D. L. A chronic illness characterised by fatigue, neurologic and immunologic disorders, and active human herpes type 6 infection. Ann. Int. Med. 116:1992;103-113.
46. Josephs S. F., Henry B., Balachandran N. HHV-6 reactivation in chronic fatigue syndrome. Lancet. 337:1991;1346-1347.